{
  "abstract": "Primary mediastinal large B-cell lymphoma (PMBCL) typically responds to chemotherapy, and immunotherapies such as chimeric antigen receptor T-cell (CAR-T) therapy and the programmed cell death protein 1 (PD-1) inhibitor pembrolizumab have shown promise in relapsed or refractory cases. However, the sequential use of multiple immunotherapies for PMBCL remains poorly characterized. Here, we report a case of a 19-year-old female with PMBCL involving the mediastinum and multiple extranodal sites. After a partial response to chemotherapy, she developed a central nervous system relapse that responded to high-dose methotrexate, and the number of regrowing mediastinal lesions was reduced by radiotherapy. Subsequently, new hepatic lesions that were refractory to both CAR-T therapy and pembrolizumab emerged. Following localized liver radiotherapy, allogeneic hematopoietic stem cell transplantation (allo-HSCT) was performed, resulting in complete response. Early post-transplant, she developed a hepatitis variant of acute graft-versus-host disease, which may have reflected a graft-versus-lymphoma (GVL) effect. Despite maintaining response, the patient died one year later form a disseminated infection with multitriazole-resistant Aspergillus fumigatus. This case highlights both the potential curative role and the substantial risks of allo-HSCT in PMBCL refractory to multiple immunotherapies. The pre-transplant use of pembrolizumab and localized radiotherapy may influence transplant outcomes and warrants further investigation.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Hematology, Endocrinology, and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan, Department of Hematopoietic Cell Therapy, Niigata University Medical and Dental Hospital, Niigata, Japan, Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, Division of Pathology, Kurume University, Fukuoka, Japan"
  ],
  "article_type": "case report",
  "arxiv": null,
  "author_total": 16,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Tatsuya Suwabe"
    },
    {
      "affs": [
        0
      ],
      "name": "Yuri Furuyama"
    },
    {
      "affs": [
        0
      ],
      "name": "Ayako Kawakami"
    },
    {
      "affs": [
        0
      ],
      "name": "Takumu Tsuchida"
    },
    {
      "affs": [
        0
      ],
      "name": "Masaki Mitobe"
    },
    {
      "affs": [
        0
      ],
      "name": "Hodaka Yonezawa"
    },
    {
      "affs": [
        0
      ],
      "name": "Takayuki Katagiri"
    },
    {
      "affs": [
        0
      ],
      "name": "Kyoko Fuse"
    },
    {
      "affs": [
        0
      ],
      "name": "Yasuhiko Shibasaki"
    },
    {
      "affs": [
        0
      ],
      "name": "Takashi Ushiki"
    },
    {
      "affs": [
        0
      ],
      "name": "Masayoshi Masuko"
    },
    {
      "affs": [
        0
      ],
      "name": "Wataru Munakata"
    },
    {
      "affs": [
        0
      ],
      "name": "Hiroaki Miyoshi"
    },
    {
      "affs": [
        0
      ],
      "name": "Koichi Ohshima"
    },
    {
      "affs": [
        0
      ],
      "name": "Hirohito Sone"
    },
    {
      "affs": [
        0
      ],
      "name": "Jun Takizawa"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ara8cqmebv7bs.bib",
  "cited_by": 0,
  "doi": "10.3960/jslrt.26007",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13759257/",
  "id": "ara8cqmebv7bs",
  "issns": [
    "1346-4280",
    "1880-9952"
  ],
  "landing_url": "https://doi.org/10.3960/jslrt.26007",
  "language": "en",
  "licence": "CC-BY-NC-SA-4.0",
  "licence_label": "CC BY-NC-SA 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Case Report"
    ],
    [
      "openalex",
      "2734|Lymphoma Diagnosis and Treatment"
    ]
  ],
  "openalex": "W7171636118",
  "pdf_url": null,
  "pmcid": "PMC13759257",
  "pmid": "42528230",
  "published": "2026-07-30",
  "publisher": "Japanese Society for Lymphoreticular Tissue Research",
  "ris": "https://research.draconitic.com/paper/ara8cqmebv7bs.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:55Z",
      "native_id": "PMC13759257",
      "source": "pmc",
      "url": "https://doi.org/10.3960/jslrt.26007"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2734|Lymphoma Diagnosis and Treatment",
      "subfield": "general"
    }
  ],
  "title": "Allogeneic hematopoietic stem cell transplantation achieves complete response in refractory primary mediastinal large B-cell lymphoma after the failure of chemotherapy, CAR-T therapy, and PD-1 blockade",
  "title_text": "Allogeneic hematopoietic stem cell transplantation achieves complete response in refractory primary mediastinal large B-cell lymphoma after the failure of chemotherapy, CAR-T therapy, and PD-1 blockade",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:55Z",
  "url": "https://research.draconitic.com/paper/ara8cqmebv7bs",
  "venue": "Journal of Clinical and Experimental Hematopathology : JCEH",
  "versions": []
}